Your browser doesn't support javascript.
loading
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
Lai, Jennifer C; Shui, Amy M; Duarte-Rojo, Andres; Ganger, Daniel R; Rahimi, Robert S; Huang, Chiung-Yu; Yao, Frederick; Kappus, Matthew; Boyarsky, Brian; McAdams-Demarco, Mara; Volk, Michael L; Dunn, Michael A; Ladner, Daniela P; Segev, Dorry L; Verna, Elizabeth C; Feng, Sandy.
Afiliação
  • Lai JC; Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
  • Shui AM; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
  • Duarte-Rojo A; Center for Liver Diseases, Thomas A. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA.
  • Ganger DR; Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Rahimi RS; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern Medicine, Chicago, Illinois, USA.
  • Huang CY; Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Baylor Scott and White, Dallas, Texas, USA.
  • Yao F; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
  • Kappus M; Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
  • Boyarsky B; Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • McAdams-Demarco M; Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Volk ML; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Dunn MA; Division of Gastroenterology & Hepatology, and Transplantation Institute, Loma Linda University Health, Loma Linda, California, USA.
  • Ladner DP; Center for Liver Diseases, Thomas A. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA.
  • Segev DL; Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Verna EC; Division of Transplantation, Department of Surgery, Northwestern Medicine, Chicago, Illinois, USA.
  • Feng S; Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Hepatology ; 75(6): 1471-1479, 2022 06.
Article em En | MEDLINE | ID: mdl-34862808
ABSTRACT
BACKGROUND AND

AIMS:

Frailty is a well-established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it predicts outcomes among those who have undergone LT is unknown. APPROACH AND

RESULTS:

Adult LT recipients from 8 US centers (2012-2019) were included. Pre-LT frailty was assessed in the ambulatory setting using the Liver Frailty Index (LFI). "Frail" was defined by an optimal cut point of LFI ≥ 4.5. We used the 75th percentile to define "prolonged" post-LT length of stay (LOS; ≥12 days), intensive care unit (ICU) days (≥4 days), and inpatient days within 90 post-LT days (≥17 days). Of 1166 LT recipients, 21% were frail pre-LT. Cumulative incidence of death at 1 and 5 years was 6% and 16% for frail and 4% and 10% for nonfrail patients (overall log-rank p = 0.02). Pre-LT frailty was associated with an unadjusted 62% increased risk of post-LT mortality (95% CI, 1.08-2.44); after adjustment for body mass index, HCC, donor age, and donation after cardiac death status, the HR was 2.13 (95% CI, 1.39-3.26). Patients who were frail versus nonfrail experienced a higher adjusted odds of prolonged LT LOS (OR, 2.00; 95% CI, 1.47-2.73), ICU stay (OR, 1.56; 95% CI, 1.12-2.14), inpatient days within 90 post-LT days (OR, 1.72; 95% CI, 1.25-2.37), and nonhome discharge (OR, 2.50; 95% CI, 1.58-3.97).

CONCLUSIONS:

Compared with nonfrail patients, frail LT recipients had a higher risk of post-LT death and greater post-LT health care utilization, although overall post-LT survival was acceptable. These data lay the foundation to investigate whether targeting pre-LT frailty will improve post-LT outcomes and reduce resource utilization.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Carcinoma Hepatocelular / Fragilidade / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Hepatology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Carcinoma Hepatocelular / Fragilidade / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Hepatology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos